Search research articles
Contact Us
Filters
Showing results (131-140 of 154) with videos related to
Page
of 16
Sort By:
The Journal of Infectious Diseases
|
April 1, 2024
Vγ9Vδ2 T-cells Are Potent Inhibitors of SARS-CoV-2 Replication and Represent Effector Phenotypes in Patients With COVID-19
Laetitia Gay, Marie-Sarah Rouviere, Soraya Mezouar, et al.
Comparative Hepatology
|
January 23, 2003
A prospective assessment of the inter-laboratory variability of biochemical markers of fibrosis (FibroTest) and activity (ActiTest) in patients with chronic liver disease
Philippe Halfon, Françoise Imbert-Bismut, Djamila Messous, et al.
Hepatology Communications
|
December 17, 2021
Hepatitis B in Senegal: A Successful Infant Vaccination Program but Urgent Need to Scale Up Screening and Treatment (ANRS 12356 AmBASS survey)
Lauren Périères, Aldiouma Diallo, Fabienne Marcellin, et al.
Journal of Cancer
|
August 18, 2021
GNS561, a New Autophagy Inhibitor Active against Cancer Stem Cells in Hepatocellular Carcinoma and Hepatic Metastasis from Colorectal Cancer
Sonia Brun, Jean-Marc Pascussi, Elena Patricia Gifu, et al.
The American Journal of Tropical Medicine and Hygiene
|
July 19, 2017
Performance of Real-Time Polymerase Chain Reaction Assays for the Detection of 20 Gastrointestinal Parasites in Clinical Samples from Senegal
Doudou Sow, Philippe Parola, Khadime Sylla, et al.
Emerging Infectious Diseases
|
January 25, 2008
Possible zoonotic transmission of hepatitis E from pet pig to its owner
Christophe Renou, Jean-Francois Cadranel, Marc Bourlière, et al.
Viruses
|
January 22, 2022
GNS561 Exhibits Potent Antiviral Activity against SARS-CoV-2 through Autophagy Inhibition
Eloïne Bestion, Keivan Zandi, Sandrine Belouzard, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
May 12, 2015
Evaluation of the COBAS(®) AmpliPrep/COBAS(®) TaqMan(®) HCV Test, v2.0 and comparison to assays used in routine clinical practice in an international multicenter clinical trial: The ExPECT study
Harald H Kessler, Bryan R Cobb, Heiner Wedemeyer, et al.
Liver Cancer
|
August 11, 2022
First-In-Human Effects of PPT1 Inhibition Using the Oral Treatment with GNS561/Ezurpimtrostat in Patients with Primary and Secondary Liver Cancers
James J Harding, Ahmad Awada, Gael Roth, et al.
The Journal of Infectious Diseases
|
September 17, 2020
A Granulocytic Signature Identifies COVID-19 and Its Severity
Joana Vitte, Aïssatou Bailo Diallo, Asma Boumaza, et al.
Page
of 16
Search research articles
Search
Showing results (131-140 of 154) with videos related to
Sort By:
Page
of 16
The Journal of Infectious Diseases
|
April 1, 2024
Vγ9Vδ2 T-cells Are Potent Inhibitors of SARS-CoV-2 Replication and Represent Effector Phenotypes in Patients With COVID-19
Laetitia Gay, Marie-Sarah Rouviere, Soraya Mezouar, et al.
Comparative Hepatology
|
January 23, 2003
A prospective assessment of the inter-laboratory variability of biochemical markers of fibrosis (FibroTest) and activity (ActiTest) in patients with chronic liver disease
Philippe Halfon, Françoise Imbert-Bismut, Djamila Messous, et al.
Hepatology Communications
|
December 17, 2021
Hepatitis B in Senegal: A Successful Infant Vaccination Program but Urgent Need to Scale Up Screening and Treatment (ANRS 12356 AmBASS survey)
Lauren Périères, Aldiouma Diallo, Fabienne Marcellin, et al.
Journal of Cancer
|
August 18, 2021
GNS561, a New Autophagy Inhibitor Active against Cancer Stem Cells in Hepatocellular Carcinoma and Hepatic Metastasis from Colorectal Cancer
Sonia Brun, Jean-Marc Pascussi, Elena Patricia Gifu, et al.
The American Journal of Tropical Medicine and Hygiene
|
July 19, 2017
Performance of Real-Time Polymerase Chain Reaction Assays for the Detection of 20 Gastrointestinal Parasites in Clinical Samples from Senegal
Doudou Sow, Philippe Parola, Khadime Sylla, et al.
Emerging Infectious Diseases
|
January 25, 2008
Possible zoonotic transmission of hepatitis E from pet pig to its owner
Christophe Renou, Jean-Francois Cadranel, Marc Bourlière, et al.
Viruses
|
January 22, 2022
GNS561 Exhibits Potent Antiviral Activity against SARS-CoV-2 through Autophagy Inhibition
Eloïne Bestion, Keivan Zandi, Sandrine Belouzard, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
May 12, 2015
Evaluation of the COBAS(®) AmpliPrep/COBAS(®) TaqMan(®) HCV Test, v2.0 and comparison to assays used in routine clinical practice in an international multicenter clinical trial: The ExPECT study
Harald H Kessler, Bryan R Cobb, Heiner Wedemeyer, et al.
Liver Cancer
|
August 11, 2022
First-In-Human Effects of PPT1 Inhibition Using the Oral Treatment with GNS561/Ezurpimtrostat in Patients with Primary and Secondary Liver Cancers
James J Harding, Ahmad Awada, Gael Roth, et al.
The Journal of Infectious Diseases
|
September 17, 2020
A Granulocytic Signature Identifies COVID-19 and Its Severity
Joana Vitte, Aïssatou Bailo Diallo, Asma Boumaza, et al.
Page
of 16